Humana Reports 3Q26 Adjusted Loss, Raises Full-Year 2026 EPS Guidance
Humana reported a Q3 2026 adjusted loss of $0.70 per share, driven by increased intangible asset amortization and investment valuation adjustments, and raised its full-year 2026 Adjusted EPS guidance to at least $9.50.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed